levoleucovorin has been researched along with Stomach-Ulcer* in 2 studies
1 review(s) available for levoleucovorin and Stomach-Ulcer
| Article | Year |
|---|---|
[Severe gastric and duodenal ulcer after chemotherapy of mFOLFOX6 and bevacizumab].
A 74-year-old female had metastatic left inguinal lymph nodes 20 months after rectal amputation for cancer, and an attempt to adapt chemotherapy of mFOLFOX6/bevacizumab was made after resection of the nodes. She felt nausea 2 days and continued 1 week after starting chemotherapy. Then, an endoscopic examination revealed both active gastric and duodenal ulcers. Clipping and proton pump inhibitor medication was started. The ulcers healed to the healing stage at 18 days and to the scar stage at 28 days. Gastrointestinal complications often occur after chemotherapy, but severe ulcers are rarely reported. The chemotherapy included anti-VEGF antibody, but the ulcers have healed back to normal. Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Duodenal Ulcer; Female; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Rectal Neoplasms; Stomach Ulcer | 2011 |
1 other study(ies) available for levoleucovorin and Stomach-Ulcer
| Article | Year |
|---|---|
[Thirteen years' survival in a patient with isolated skin metastases of a gastric carcinoma. What kind of disease is that?].
Gastric adenocarcinoma is a high-lethality tumour and has a great tendency to recur. Liver and peritoneum are the places where the metastases are most frequently localised. We introduce the case of a woman diagnosed with gastric adenocarcinoma who showed isolated skin metastasis. There were an important number of recurrences (always in the skin). She was treated with radical surgery and later treated with different cytostatic schedules. The patient died 13 years after metastasis were diagnosed. With this case we wanted to pay attention to the role of the biologic prognostic factors of gastric carcinoma. The molecular biology of these tumours can explain the different evolution of the disease. Biologic prognostic factors can separate gastric carcinoma into different kinds of disease. Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Fluorouracil; Gastroenterostomy; Humans; Leucovorin; Middle Aged; Radioisotope Teletherapy; Shoulder; Skin Neoplasms; Stomach Neoplasms; Stomach Ulcer; Survivors | 2003 |